Viviane Tabar, MD

Memorial Sloan Kettering Cancer Center, USA

Viviane Tabar, MD is a neurosurgeon scientist and Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York.
Her research includes the development of cell-based therapies for neurological disorders, using human pluripotent stem cells. This portfolio includes the development of human pluripotent stem cell-derived dopamine neurons for Parkinson’s disease, and the completion of a recent first in human Phase I clinical trial. Her lab has also studies glioma biology and has pioneered the use of human embryonic stem cell-based models of brain tumors, with a focus on histone-mutant high grade glioma. She is a member of the American Society for Clinical Investigation and the National Academy of Medicine.

Presentation(s):

• BLUEROCK CLINICAL TRIALS WORKSHOP SPECIAL SESSION: ADVANCES IN THE TREATMENT OF PARKINSON’S DISEASE: THE POSSIBILITIES OF CELL THERAPIES

  Wednesday, July 10, 2024
  12:00 PM – 1:00 PM CEST

• PSC-BASED CELL THERAPIES

  Friday, July 12, 2024
  1:30 PM – 3:00 PM CEST

• UPDATES ON CLINICAL TRIALS

  Saturday, July 13, 2024
  8:15 AM – 9:45 AM CEST

• PHASE I CLINICAL TRIAL OF HUMAN ES-DERIVED DOPAMINE NEURONS GRAFTS FOR PARKINSON'S DISEASE: 18 MONTHS DATA

  Saturday, July 13, 2024
  8:20 AM – 8:40 AM CEST